Showing 5,561 - 5,580 results of 15,663 for search '(( six ((nn decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.85s Refine Results
  1. 5561

    A catalogue of dynamic, non-linear genetic effects in gene response following rapamycin treatment in yeast. by Avital Brodt (669454)

    Published 2014
    “…<p>(<b>A</b>) Genetic effect profiles (left) and gene expression profiles (right) at six time points following rapamycin treatment (columns) for all genes identified by DyVER. …”
  2. 5562

    Image_1_Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis.png by Po Huang (8171661)

    Published 2019
    “…Stata software (version 11.0, Stata Corp LP, College Station, TX, USA) was used for statistical analysis.</p><p>Results: A total of six studies were identified and incorporated into the meta-analysis. …”
  3. 5563

    Image_3_Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis.tif by Po Huang (8171661)

    Published 2019
    “…Stata software (version 11.0, Stata Corp LP, College Station, TX, USA) was used for statistical analysis.</p><p>Results: A total of six studies were identified and incorporated into the meta-analysis. …”
  4. 5564

    Image_5_Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis.tif by Po Huang (8171661)

    Published 2019
    “…Stata software (version 11.0, Stata Corp LP, College Station, TX, USA) was used for statistical analysis.</p><p>Results: A total of six studies were identified and incorporated into the meta-analysis. …”
  5. 5565
  6. 5566
  7. 5567

    Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI by Ingmar L. Defize (8833499)

    Published 2020
    “…Tumor volume regression started after the first week of nCRT with a significant decrease in tumor volumes every subsequent week. …”
  8. 5568

    Function, design, and expected use of <i>Gemini</i>, a bifunctional reporter of gene expression. by Lance Martin (257830)

    Published 2009
    “…Full-length GFP is fused with a 19 amino acid linker containing a six Histidine tag and predominantly Glycine and Serine residues to the β-gal α-fragment. …”
  9. 5569
  10. 5570

    Estimating the Effect of Liver and Pancreas Volume and Fat Content on Risk of Diabetes: A Mendelian Randomization Study by Susan Martin (6648740)

    Published 2022
    “…We obtained summary-level data for risk of type 1 (9,358 cases) and type 2 (55,005 cases) diabetes from the largest available genome-wide association studies. …”
  11. 5571

    T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial by Dimitrios Karussis (110032)

    Published 2012
    “…</p> <h3>Aim</h3><p>To evaluate the safety and efficacy of TCV in progressive MS, in a double-blind, controlled clinical trial.</p> <h3>Methodology</h3><p>Twenty-six patients with relapsing-progressive MS were enrolled in the study (mean age: 39±9.8 years; mean EDSS: 4.4±1.7). …”
  12. 5572

    Effects of huperzine A on hippocampal inflammatory response and neurotrophic factors in aged rats after anesthesia by Yi Cai (233861)

    Published 2020
    “…Methods Thirty-six Sprague Dawley rats (20-22 months old) were randomly divided into control, isofluran, and isoflurane+HupA groups; 12 rats in each group. …”
  13. 5573

    Cardiorespiratory/sedative effects of a peptide identified in crotalic venom compared to acepromazine and xylazine in horses by C. J. X. Abimussi (16562532)

    Published 2023
    “…<div><p>ABSTRACT The purpose of this study was to investigate whether intravenous crotalphine produces significant sedation, as well as physiological changes, in healthy standing horses. Six mares, aged 8 years and weighing 415kg underwent three different treatments in a crossover design: TA (acepromazine: 50μg.kg-1), TC (crotalphine: 0.01μg.kg-1) and TX (xylazine: 1000μg.kg-1), intravenously. …”
  14. 5574
  15. 5575

    The clinical significance of neopterin and NT-pro BNP in chronic heart failure: a systematic review by Gaidaa M. Dogheim (18892902)

    Published 2024
    “…The aim of this study is to evaluate neopterin and NT-pro BNP as diagnostic and prognostic biomarkers in HF.</p> <p>A systematic search was conducted in six electronic databases from inception to July 24th, 2022. …”
  16. 5576

    Data Sheet 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  17. 5577

    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  18. 5578

    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  19. 5579

    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”
  20. 5580

    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…Further, certain modules of genes with co-occurring genomic alterations had dose-dependent relationships with histology and increasing or decreasing levels of PD-L1 and TMB, suggesting a complex relationship between PD-L1, TMB, and genomic alterations in these gene modules.…”